Mobia Medical appoints Reza Zadno, Ph.D. to board, expands to 7 members

Mobia Medical, Inc.

Board increased from 6 to 7; Dr. Zadno appointed as Class III director, term through 2029 annual meeting.
Dr. Zadno is independent and will serve on Compensation Committee; Dr. Harrington resigned from that committee.
Previously CEO of PROCEPT BioRobotics (PRCT) and Avedro (now part of Glaukos, GKOS).
Will receive standard non-employee director compensation; no related-party transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.